MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | 0.0% | 970 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | 0.0% | 970 | 0.0% | 0.00% | – |
| Q1 2023 | $1 | 0.0% | 970 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 970 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 970 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 970 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 970 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 970 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 970 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 970 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | – | 970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 16,756,120 | $18,767,000 | 0.99% |
| Clearline Capital LP | 3,058,596 | $3,426,000 | 0.44% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9,142,067 | $10,239,000 | 0.39% |
| DAFNA Capital Management LLC | 1,096,513 | $1,228,000 | 0.34% |
| Octagon Capital Advisors LP | 1,000,000 | $1,120,000 | 0.30% |
| Rock Springs Capital Management LP | 6,230,275 | $6,978,000 | 0.20% |
| Boxer Capital, LLC | 2,250,000 | $2,520,000 | 0.16% |
| Orbimed Advisors | 7,109,954 | $7,963,000 | 0.14% |
| Artal Group S.A. | 1,500,000 | $1,680,000 | 0.09% |
| SECTORAL ASSET MANAGEMENT INC | 385,000 | $431,000 | 0.09% |